0000921895-19-000500.txt : 20190214 0000921895-19-000500.hdr.sgml : 20190214 20190214215546 ACCESSION NUMBER: 0000921895-19-000500 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190211 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COUCHMAN JONATHAN CENTRAL INDEX KEY: 0001265094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 19609679 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Couchman Family Fund CENTRAL INDEX KEY: 0001737322 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 19609680 BUSINESS ADDRESS: STREET 1: 630 FIFTH AVENUE, SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: (212) 729-4962 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE, SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xstelos Corp. CENTRAL INDEX KEY: 0001571659 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36435 FILM NUMBER: 19609681 BUSINESS ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212.729.4962 MAIL ADDRESS: STREET 1: 630 FIFTH AVENUE STREET 2: SUITE 2260 CITY: NEW YORK STATE: NY ZIP: 10020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 COMMERCE DRIVE, SUITE 135 CITY: CRANFORD STATE: NJ ZIP: 07016 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 COMMERCE DRIVE, SUITE 135 CITY: CRANFORD STATE: NJ ZIP: 07016 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060324 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 4 1 form407216001_02142019.xml OWNERSHIP DOCUMENT X0306 4 2019-02-11 0 0000727510 ENZON PHARMACEUTICALS, INC. ENZN 0001265094 COUCHMAN JONATHAN 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020 0 0 1 0 0001737322 Couchman Family Fund 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020 0 0 1 0 0001571659 Xstelos Corp. 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020 0 0 1 0 Common Stock, $0.01 par value 2019-02-11 4 P 0 15500 0.25 A 4697166 D Common Stock, $0.01 par value 2019-02-11 4 P 0 10000 0.25 A 4707166 D Common Stock, $0.01 par value 2019-02-11 4 P 0 500 0.25 A 4707666 D Common Stock, $0.01 par value 2019-02-11 4 P 0 10000 0.25 A 4717666 D Common Stock, $0.01 par value 2019-02-11 4 P 0 10000 0.25 A 1569523 I By Xstelos Corp. Common Stock, $0.01 par value 2019-02-11 4 P 0 5000 0.25 A 1574523 I By Xstelos Corp. Common Stock, $0.01 par value 400000 I By Couchman Family Fund This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation") and Xstelos Corp. ("Xstelos" and, together with Mr. Couchman and the Foundation, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose. Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein. Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares. /s/ Jonathan Couchman 2019-02-14 Couchman Family Fund; By: /s/ Jonathan Couchman, Trustee 2019-02-14 Xstelos Corp.; By: /s/ Jonathan Couchman, Chief Executive Officer 2019-02-14